Pub Date : 2025-07-17DOI: 10.1021/acsbiomedchemau.5c00085
Alaa Aziz, Desiree R. Czapski, Ravi Ramkissoon, Md Sabid Ahamed, Sarah Al-Noubani, Andrew J. Mier, Oreoluwa Adeleke, Sharel Cornelius, Saiful Chowdhury, Frank W. Foss Jr, Joseph A. Buonomo, Ghader Bashiri and Kayunta L. Johnson-Winters*,
F420-dependent glucose-6-phosphate dehydrogenase (FGD) catalyzes the oxidation of glucose-6-phosphate (G6P) to 6-phosphogluconolactone (6PG). Recent phylogenetic analyses have identified a new subclass of these enzymes, F420-dependent sugar-6-phosphate dehydrogenases (FSDs), which act on a broader range of 6-phosphate sugars, including fructose-6-phosphate (F6P) and mannose-6-phosphate (M6P). One such enzyme from Cryptosporangium arvum (Cryar-FGD) was characterized by using binding assays and kinetic analyses, nuclear magnetic resonance (NMR), and mass spectrometry. Results showed strong binding affinities for all substrates. Steady-state kinetic analysis revealed that G6P has the highest catalytic efficiency, with a kcat(app) of 6.4 ± 0.2 s–1, compared to 1.4 ± 0.1 s–1 for F6P and 0.32 ± 0.02 s–1 for M6P. Pre steady-state spectral features for the G6P reaction resembled those of Mycobacterium tuberculosis FGD. While the F6P reaction displayed distinct spectral features, F420 reduction was still observed. In contrast, the spectra for the M6P reaction were markedly different from those of G6P and F6P. Across all substrates, no catalytic intermediates were detected, and hydride transfer was not rate-limiting. As with G6P, the reaction with F6P also produced 6PG. Notably, NMR data showed that F6P was isomerized to G6P, suggesting isomerase activity. In contrast, M6P induced only spectral shifts with no evidence of isomerization or 6PG formation. However, mass spectrometry confirmed oxidized products for all three sugars, each with a mass of 299.0 ± 0.1. Collectively, these findings reveal that Cryar-FGD exhibits both dehydrogenase and isomerase activity, uncovering a newly identified dual enzymatic function and establishing its role as a multifunctional enzyme.
{"title":"Kinetic Characterization of F420-Dependent Sugar-6-Phosphate Dehydrogenase from Cryptosporangium arvum","authors":"Alaa Aziz, Desiree R. Czapski, Ravi Ramkissoon, Md Sabid Ahamed, Sarah Al-Noubani, Andrew J. Mier, Oreoluwa Adeleke, Sharel Cornelius, Saiful Chowdhury, Frank W. Foss Jr, Joseph A. Buonomo, Ghader Bashiri and Kayunta L. Johnson-Winters*, ","doi":"10.1021/acsbiomedchemau.5c00085","DOIUrl":"https://doi.org/10.1021/acsbiomedchemau.5c00085","url":null,"abstract":"<p ><i>F</i><sub>420</sub>-dependent glucose-6-phosphate dehydrogenase (FGD) catalyzes the oxidation of glucose-6-phosphate (G6P) to 6-phosphogluconolactone (6PG). Recent phylogenetic analyses have identified a new subclass of these enzymes, <i>F</i><sub>420</sub>-dependent sugar-6-phosphate dehydrogenases (FSDs), which act on a broader range of 6-phosphate sugars, including fructose-6-phosphate (F6P) and mannose-6-phosphate (M6P). One such enzyme from <i>Cryptosporangium arvum</i> (<i>Cryar</i>-FGD) was characterized by using binding assays and kinetic analyses, nuclear magnetic resonance (NMR), and mass spectrometry. Results showed strong binding affinities for all substrates. Steady-state kinetic analysis revealed that G6P has the highest catalytic efficiency, with a <i>k</i><sub>cat(app)</sub> of 6.4 ± 0.2 s<sup>–1</sup>, compared to 1.4 ± 0.1 s<sup>–1</sup> for F6P and 0.32 ± 0.02 s<sup>–1</sup> for M6P. Pre steady-state spectral features for the G6P reaction resembled those of <i>Mycobacterium tuberculosis</i> FGD. While the F6P reaction displayed distinct spectral features, <i>F</i><sub>420</sub> reduction was still observed. In contrast, the spectra for the M6P reaction were markedly different from those of G6P and F6P. Across all substrates, no catalytic intermediates were detected, and hydride transfer was not rate-limiting. As with G6P, the reaction with F6P also produced 6PG. Notably, NMR data showed that F6P was isomerized to G6P, suggesting isomerase activity. In contrast, M6P induced only spectral shifts with no evidence of isomerization or 6PG formation. However, mass spectrometry confirmed oxidized products for all three sugars, each with a mass of 299.0 ± 0.1. Collectively, these findings reveal that <i>Cryar</i>-FGD exhibits both dehydrogenase and isomerase activity, uncovering a newly identified dual enzymatic function and establishing its role as a multifunctional enzyme.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 4","pages":"726–737"},"PeriodicalIF":4.3,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsbiomedchemau.5c00085","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144863093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-12DOI: 10.1021/acsbiomedchemau.5c00114
Sudeshi M. Abedeera, Mary Donnelly, James Hagerty, Shaila Kolli, Srinivasa R. Penumutchu, Louis G. Smith and Blanton S. Tolbert*,
RNA biology exemplifies functional heterogeneity─distinct RNA classes are expressed in tissue- and development-specific contexts, adopt dynamic conformational ensembles, and form intricate, context-dependent interactions with proteins and other molecules to regulate gene expression. These features make RNA a powerful metaphor for reimagining scientific culture. Just as RNA achieves biological complexity through versatility, feedback loops, and communication, research environments thrive when they support dynamic interactions, structural adaptability, and the intentional inclusion of divergent perspectives and experiences. However, unlike RNA, research culture is shaped by human behavior, institutional norms, and systemic barriers─forces that can suppress innovation and limit who contributes to scientific discovery. Scientific excellence demands the integration of wide-ranging perspectives to challenge paradigms and push boundaries. Yet entrenched structures often reward conformity and marginalize creativity born from difference. By embracing the principles inherent to RNA biology─contextual responsiveness, structural plasticity, and cooperativity─we can transform scientific culture into one that is more inclusive, welcoming, and adaptable. This perspective argues that the biological elegance of RNA offers more than molecular insight; it provides a conceptual framework for building research environments that harness the full spectrum of talent in our richly heterogeneous society, ultimately accelerating scientific progress and broadening its societal impact.
{"title":"Toward a Beautiful Amalgam: The Necessity of Heterogeneity in RNA Science and Research Culture","authors":"Sudeshi M. Abedeera, Mary Donnelly, James Hagerty, Shaila Kolli, Srinivasa R. Penumutchu, Louis G. Smith and Blanton S. Tolbert*, ","doi":"10.1021/acsbiomedchemau.5c00114","DOIUrl":"https://doi.org/10.1021/acsbiomedchemau.5c00114","url":null,"abstract":"<p >RNA biology exemplifies functional heterogeneity─distinct RNA classes are expressed in tissue- and development-specific contexts, adopt dynamic conformational ensembles, and form intricate, context-dependent interactions with proteins and other molecules to regulate gene expression. These features make RNA a powerful metaphor for reimagining scientific culture. Just as RNA achieves biological complexity through versatility, feedback loops, and communication, research environments thrive when they support dynamic interactions, structural adaptability, and the intentional inclusion of divergent perspectives and experiences. However, unlike RNA, research culture is shaped by human behavior, institutional norms, and systemic barriers─forces that can suppress innovation and limit who contributes to scientific discovery. Scientific excellence demands the integration of wide-ranging perspectives to challenge paradigms and push boundaries. Yet entrenched structures often reward conformity and marginalize creativity born from difference. By embracing the principles inherent to RNA biology─contextual responsiveness, structural plasticity, and cooperativity─we can transform scientific culture into one that is more inclusive, welcoming, and adaptable. This perspective argues that the biological elegance of RNA offers more than molecular insight; it provides a conceptual framework for building research environments that harness the full spectrum of talent in our richly heterogeneous society, ultimately accelerating scientific progress and broadening its societal impact.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 4","pages":"519–530"},"PeriodicalIF":4.3,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsbiomedchemau.5c00114","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144863126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-10DOI: 10.1021/acsbiomedchemau.5c00143
Squire J. Booker, Stephanie L. Brock, Xiangdong Li, Géraldine Masson, Sébastien Perrier, Vivek V. Ranade, Raymond E. Schaak, Gemma C. Solomon and Shelley D. Minteer*,
{"title":"Introducing the Tutorial Manuscript Type at the ACS Au Community Journals","authors":"Squire J. Booker, Stephanie L. Brock, Xiangdong Li, Géraldine Masson, Sébastien Perrier, Vivek V. Ranade, Raymond E. Schaak, Gemma C. Solomon and Shelley D. Minteer*, ","doi":"10.1021/acsbiomedchemau.5c00143","DOIUrl":"https://doi.org/10.1021/acsbiomedchemau.5c00143","url":null,"abstract":"","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 4","pages":"484–485"},"PeriodicalIF":4.3,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsbiomedchemau.5c00143","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144862844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-08DOI: 10.1021/acsbiomedchemau.5c00084
Navleen Kaur, Kinjal Mondal, Megan E. Mitchell, Sarala Padi, Jeffery B. Klauda, Antonio Cardone, Frank Heinrich, Christina R. Harris, David K. Giles, Mary T. Rooney, Erik B. Watkins, Myriam L. Cotten, David P. Hoogerheide and Mihaela Mihailescu*,
Sequence motifs or patterns found in natural antimicrobial peptides (AMPs) have a great impact on their microbicidal activities. Here, through database inquiries and biological assays, we explore the enhanced antibacterial function associated with poly arginine (poly-R) motifs that typically occur as 3–5 concatenated R residues in many natural AMPs. Using a suite of biophysical techniques, we explore the structural consequences of a C-terminal poly-R motif at membranes and correlate our findings with the functional assays. We use natural peptides, such as Tilapia piscidin 4 (TP4), as an example of how various segments in an AMP play separate and synergistic roles to achieve unmatched bactericidal effects. The function of the poly-R segment is highly consequential since the simple addition of a five-arginine (R5) tail to an otherwise inert and weakly binding helical peptide creates a potent AMP. We investigate interactions of AMPs with lipid bilayers mimicking bacterial membrane compositions, including lipopolysaccharides, to show that the poly-R tail has a key role in initiating membrane destabilization through lipid segregation and water sequestration effects, all of which facilitate insertion and translocation of the amphipathic, α-helical N-terminal segment through the membrane. We compiled a large set of natural AMP sequences and MIC values to show that, statistically, the poly-R sequence motifs have, in average, a greater impact on the overall antimicrobial efficacy than equivalent sequences with poly-K motifs and similar charge densities. We discuss our observations in light of the unique structural and hydration properties of arginine residues.
{"title":"Poly-Arginine Tails and Helical Segments of Natural Antimicrobial Peptides Display Concerted Action at Membranes for Enhanced Antimicrobial Effects","authors":"Navleen Kaur, Kinjal Mondal, Megan E. Mitchell, Sarala Padi, Jeffery B. Klauda, Antonio Cardone, Frank Heinrich, Christina R. Harris, David K. Giles, Mary T. Rooney, Erik B. Watkins, Myriam L. Cotten, David P. Hoogerheide and Mihaela Mihailescu*, ","doi":"10.1021/acsbiomedchemau.5c00084","DOIUrl":"https://doi.org/10.1021/acsbiomedchemau.5c00084","url":null,"abstract":"<p >Sequence motifs or patterns found in natural antimicrobial peptides (AMPs) have a great impact on their microbicidal activities. Here, through database inquiries and biological assays, we explore the enhanced antibacterial function associated with poly arginine (poly-R) motifs that typically occur as 3–5 concatenated R residues in many natural AMPs. Using a suite of biophysical techniques, we explore the structural consequences of a C-terminal poly-R motif at membranes and correlate our findings with the functional assays. We use natural peptides, such as Tilapia piscidin 4 (TP4), as an example of how various segments in an AMP play separate and synergistic roles to achieve unmatched bactericidal effects. The function of the poly-R segment is highly consequential since the simple addition of a five-arginine (R5) tail to an otherwise inert and weakly binding helical peptide creates a potent AMP. We investigate interactions of AMPs with lipid bilayers mimicking bacterial membrane compositions, including lipopolysaccharides, to show that the poly-R tail has a key role in initiating membrane destabilization through lipid segregation and water sequestration effects, all of which facilitate insertion and translocation of the amphipathic, α-helical N-terminal segment through the membrane. We compiled a large set of natural AMP sequences and MIC values to show that, statistically, the poly-R sequence motifs have, in average, a greater impact on the overall antimicrobial efficacy than equivalent sequences with poly-K motifs and similar charge densities. We discuss our observations in light of the unique structural and hydration properties of arginine residues.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 4","pages":"706–725"},"PeriodicalIF":4.3,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsbiomedchemau.5c00084","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144863165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-08DOI: 10.1021/acsbiomedchemau.5c00074
Henry A. Adeola, and , Renã A. S. Robinson*,
Alzheimer’s disease (AD) and AD-related dementias (ADRD) represent a significant health challenge, with a growing impact on marginalized populations who often experience inequities in overall healthcare access and outcomes. Many factors contribute to these inequalities and can impact the benefits of broad appreciation of new technologies in AD/ADRD to these populations. For example, clinical proteomics offers a promising avenue for early and timely detection of disease and elucidation of the mechanisms of AD/ADRD. Unfortunately, gaps exist in the access and application of proteomic innovations for the health of marginalized communities. This editorial (1) highlights systemic barriers and explores the underlying factors that contribute to these inequities, (2) examines health disparities in the implementation of clinical proteomics tools for the management of AD/ADRD among marginalized populations, and (3) offers opportunities for advancing clinical proteomics in AD/ADRD. Implementation by basic and clinical researchers will lead to a more effective and inclusive approach to combatting AD/ADRD disparities.
{"title":"Bridging Health Disparity Gaps in Alzheimer’s Disease among Marginalized Populations: Clinical Proteomics as a Case Study","authors":"Henry A. Adeola, and , Renã A. S. Robinson*, ","doi":"10.1021/acsbiomedchemau.5c00074","DOIUrl":"https://doi.org/10.1021/acsbiomedchemau.5c00074","url":null,"abstract":"<p >Alzheimer’s disease (AD) and AD-related dementias (ADRD) represent a significant health challenge, with a growing impact on marginalized populations who often experience inequities in overall healthcare access and outcomes. Many factors contribute to these inequalities and can impact the benefits of broad appreciation of new technologies in AD/ADRD to these populations. For example, clinical proteomics offers a promising avenue for early and timely detection of disease and elucidation of the mechanisms of AD/ADRD. Unfortunately, gaps exist in the access and application of proteomic innovations for the health of marginalized communities. This editorial (1) highlights systemic barriers and explores the underlying factors that contribute to these inequities, (2) examines health disparities in the implementation of clinical proteomics tools for the management of AD/ADRD among marginalized populations, and (3) offers opportunities for advancing clinical proteomics in AD/ADRD. Implementation by basic and clinical researchers will lead to a more effective and inclusive approach to combatting AD/ADRD disparities.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 4","pages":"505–518"},"PeriodicalIF":4.3,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsbiomedchemau.5c00074","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144863167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-02DOI: 10.1021/acsbiomedchemau.5c00103
László Galgóczy*,
The prevalence of fungal infections and contamination has increased alarmingly over the past decade, posing a significant threat to human health and the food supply and negatively affecting welfare. This escalating concern is primarily attributed to the lack of safe, effective, and widely available antifungal agents; the increasing spread of (multi)drug resistance to conventional antifungal treatments; and substantial epidemiological shifts in fungal pathogens. Decision-making bodies have recognized the urgency of this situation and prioritized efforts to address and mitigate the spread of drug-resistant fungal infections by developing and implementing innovative antifungal strategies, including using drug combinations, designing fundamentally new antifungal compounds with fungus-specific mechanisms of action and a minimal risk of resistance development, drug repurposing, and exploring alternative approaches, such as biomolecules, nanotechnology, and biological control. This review aims to provide a comprehensive overview of the current challenges associated with fungal infections in medicine and agriculture as well as the latest advancements and potential solutions.
{"title":"Overcoming Global Antifungal Challenges: Medical and Agricultural Aspects","authors":"László Galgóczy*, ","doi":"10.1021/acsbiomedchemau.5c00103","DOIUrl":"https://doi.org/10.1021/acsbiomedchemau.5c00103","url":null,"abstract":"<p >The prevalence of fungal infections and contamination has increased alarmingly over the past decade, posing a significant threat to human health and the food supply and negatively affecting welfare. This escalating concern is primarily attributed to the lack of safe, effective, and widely available antifungal agents; the increasing spread of (multi)drug resistance to conventional antifungal treatments; and substantial epidemiological shifts in fungal pathogens. Decision-making bodies have recognized the urgency of this situation and prioritized efforts to address and mitigate the spread of drug-resistant fungal infections by developing and implementing innovative antifungal strategies, including using drug combinations, designing fundamentally new antifungal compounds with fungus-specific mechanisms of action and a minimal risk of resistance development, drug repurposing, and exploring alternative approaches, such as biomolecules, nanotechnology, and biological control. This review aims to provide a comprehensive overview of the current challenges associated with fungal infections in medicine and agriculture as well as the latest advancements and potential solutions.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 4","pages":"531–552"},"PeriodicalIF":4.3,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsbiomedchemau.5c00103","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144863059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-02DOI: 10.1021/acsbiomedchemau.4c00146
Christopher M. Bourne, Nicole R. Raniszewski, Ashutosh B. Mahale, Madhura Kulkarni, Patrick M. Exconde, Sherry Liu, Winslow Yost, Tristan J. Wrong, Robert C. Patio, Matilda Kardhashi, Teni Shosanya, Mirai Kambayashi, Bohdana M. Discher, Igor E. Brodsky, George M. Burslem* and Cornelius Y. Taabazuing*,
Caspases are a family of cysteine proteases that act as molecular scissors to cleave substrates and regulate biological processes, such as programmed cell death and inflammation. Extensive efforts have been made to identify caspase substrates and to determine the factors that dictate specificity. We recently discovered that human inflammatory caspases (caspases-1, -4, and -5) cleave the cytokines IL-1β and IL-18 in a sequence-dependent manner. Here, we report the development of a new peptide-based probe and inhibitor derived from the tetrapeptide sequence of IL-18 (LESD). The LESD-based inhibitor showed a strong preference for caspase-8 with an IC50 of 50 nM, and was more potent in vitro than the commonly used zIETD-FMK inhibitor, which is considered the most selective and potent caspase-8 inhibitor. We further demonstrated that the LESD-based inhibitor prevents caspase-8 activation during Yersinia pseudotuberculosis infection in primary bone marrow-derived macrophages. In addition, we systematically characterized the selectivity and potency of known substrates and inhibitors of the apoptotic and inflammatory caspases using standardized activity units of each caspase. Our findings reveal that VX-765, a known inhibitor of caspases-1 and -4, also inhibits caspase-8 (IC50 = 1 μM). Even when specificities are shared, the caspases exhibit different efficiencies and potencies for shared substrates and inhibitors. Altogether, we report the development of new tools that will facilitate the study of caspases and their roles in biology.
{"title":"A Potent Inhibitor of Caspase-8 Based on the IL-18 Tetrapeptide Sequence Reveals Shared Specificities between Inflammatory and Apoptotic Initiator Caspases","authors":"Christopher M. Bourne, Nicole R. Raniszewski, Ashutosh B. Mahale, Madhura Kulkarni, Patrick M. Exconde, Sherry Liu, Winslow Yost, Tristan J. Wrong, Robert C. Patio, Matilda Kardhashi, Teni Shosanya, Mirai Kambayashi, Bohdana M. Discher, Igor E. Brodsky, George M. Burslem* and Cornelius Y. Taabazuing*, ","doi":"10.1021/acsbiomedchemau.4c00146","DOIUrl":"https://doi.org/10.1021/acsbiomedchemau.4c00146","url":null,"abstract":"<p >Caspases are a family of cysteine proteases that act as molecular scissors to cleave substrates and regulate biological processes, such as programmed cell death and inflammation. Extensive efforts have been made to identify caspase substrates and to determine the factors that dictate specificity. We recently discovered that human inflammatory caspases (caspases-1, -4, and -5) cleave the cytokines IL-1β and IL-18 in a sequence-dependent manner. Here, we report the development of a new peptide-based probe and inhibitor derived from the tetrapeptide sequence of IL-18 (LESD). The LESD-based inhibitor showed a strong preference for caspase-8 with an IC<sub>50</sub> of 50 nM, and was more potent <i>in vitro</i> than the commonly used zIETD-FMK inhibitor, which is considered the most selective and potent caspase-8 inhibitor. We further demonstrated that the LESD-based inhibitor prevents caspase-8 activation during <i>Yersinia pseudotuberculosis</i> infection in primary bone marrow-derived macrophages. In addition, we systematically characterized the selectivity and potency of known substrates and inhibitors of the apoptotic and inflammatory caspases using standardized activity units of each caspase. Our findings reveal that VX-765, a known inhibitor of caspases-1 and -4, also inhibits caspase-8 (IC<sub>50</sub> = 1 μM). Even when specificities are shared, the caspases exhibit different efficiencies and potencies for shared substrates and inhibitors. Altogether, we report the development of new tools that will facilitate the study of caspases and their roles in biology.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 4","pages":"565–581"},"PeriodicalIF":4.3,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsbiomedchemau.4c00146","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144863060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-30DOI: 10.1021/acsbiomedchemau.5c00159
Squire J. Booker, and , Tamra C. Blue-Lahom,
{"title":"ACS Bio & Med Chem Au Recognizes Juneteenth 2025","authors":"Squire J. Booker, and , Tamra C. Blue-Lahom, ","doi":"10.1021/acsbiomedchemau.5c00159","DOIUrl":"https://doi.org/10.1021/acsbiomedchemau.5c00159","url":null,"abstract":"","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 4","pages":"475–483"},"PeriodicalIF":4.3,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsbiomedchemau.5c00159","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144863073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-30DOI: 10.1021/acsbiomedchemau.5c00012
Siva Bandi, Marie-Désirée Schlemper-Scheidt, Rocío Rivera Sánchez, Sylvain Sutour, Gaétan Glauser, Yojiro Ishida and Stephan H. von Reuß*,
N-acyl ethanolamines represent conserved lipophilic signaling molecules that function as endogenous ligands at G-protein-coupled receptors, ion channels, and nuclear receptors. Using a combination of comparative ultrahigh-performance liquid chromatography electrospray ionization high-resolution tandem mass spectrometry (UHPLC-ESI-HR-MSE) analysis and microreactions, a diversity of glycosylated N-acyl phosphoethanolamines were characterized in Caenorhabditis nematodes. Representative examples were enriched by RP-C18 chromatography and identified by NMR spectroscopy. Comparative metabolomics and isotope incorporation experiments revealed that the biosynthesis of the homologous N-acyl building blocks (approximately 50 compounds) depends on the bacterial food source, chain elongation and desaturation of food-derived fatty acids, or their de novo biosynthesis by the nematode, whereas the biosynthesis of medium-chain N-acyl units depends on the peroxisomal β-oxidation cycle via the 3-ketoacyl-S-CoA thiolase daf-22. Glycosylation of these lipophilic N-acyl ethanolamines results in amphiphilic modular metabolites (approximately 100 identified compounds) that are released into the environment and exhibit potential signaling functions. Exclusively male-produced β-sophorosyl N-acyl-phosphoethanolamines like SNAP-13:1cyclo retain females of Caenorhabditis wallacei and Caenorhabditis brenneri, and its biosynthesis requires bacterial cyclo fatty acids 17:1cyclo and 19:1cyclo, thereby translating growth phase-dependent bacterial lipogeneses into a behavioral signal. Amphiphilic 2-(β-glucosyl)-glyceryl N-eicosapentaenoyl phosphoethanolamine (GGp-NAE-20:5), a dominating component of the Caenorhabditis elegans metabolome, represents a water-soluble derivative of N-eicosapentaenoyl ethanolamine (NAE 20:5), potentially enabling intra- and interspecies endocannabinoid signaling.
n-酰基乙醇胺是一种保守的亲脂性信号分子,在g蛋白偶联受体、离子通道和核受体上起内源性配体的作用。采用比较超高效液相色谱-电喷雾电离高分辨率串联质谱(UHPLC-ESI-HR-MSE)分析和微反应相结合的方法,对隐杆线虫中n -酰基磷酸乙醇胺的多样性进行了表征。代表性样品经RP-C18色谱富集,核磁共振鉴定。比较代谢组学和同位素结合实验表明,同源n -酰基构建块(大约50种化合物)的生物合成取决于细菌食物来源、食物来源脂肪酸的链延伸和去饱和,或线虫的新生生物合成,而中链n -酰基单元的生物合成取决于通过3-酮酰基- s -辅酶a硫酶daf-22进行的过氧化物酶体β-氧化循环。这些亲脂性n -酰基乙醇胺的糖基化产生两亲性模块化代谢物(大约100种已确定的化合物),这些代谢物被释放到环境中并表现出潜在的信号功能。只有雄性产生的β-sophorosyl n -酰基磷酸乙醇胺,如snap13:1cyclo,保留了wallacei和brenneri Caenorhabditis的雌性,其生物合成需要细菌环脂肪酸17:1cyclo和19:1cyclo,从而将生长阶段依赖性的细菌脂肪生成转化为行为信号。2-(β-葡萄糖基)-甘油三酯n -二十碳五烯烯基磷酸乙醇胺(GGp-NAE-20:5)是秀丽隐线虫代谢组的主要成分,是n -二十碳五烯烯基乙醇胺(NAE 20:5)的水溶性衍生物,可能实现种内和种间内源性大麻素信号传导。
{"title":"Glycosylated N-Acyl Phosphoethanolamines as Bacterial Food-Dependent Signaling Molecules in Caenorhabditis Nematodes","authors":"Siva Bandi, Marie-Désirée Schlemper-Scheidt, Rocío Rivera Sánchez, Sylvain Sutour, Gaétan Glauser, Yojiro Ishida and Stephan H. von Reuß*, ","doi":"10.1021/acsbiomedchemau.5c00012","DOIUrl":"https://doi.org/10.1021/acsbiomedchemau.5c00012","url":null,"abstract":"<p ><i>N</i>-acyl ethanolamines represent conserved lipophilic signaling molecules that function as endogenous ligands at G-protein-coupled receptors, ion channels, and nuclear receptors. Using a combination of comparative ultrahigh-performance liquid chromatography electrospray ionization high-resolution tandem mass spectrometry (UHPLC-ESI-HR-MS<sup>E</sup>) analysis and microreactions, a diversity of glycosylated <i>N</i>-acyl phosphoethanolamines were characterized in <i>Caenorhabditis</i> nematodes. Representative examples were enriched by RP-C18 chromatography and identified by NMR spectroscopy. Comparative metabolomics and isotope incorporation experiments revealed that the biosynthesis of the homologous <i>N</i>-acyl building blocks (approximately 50 compounds) depends on the bacterial food source, chain elongation and desaturation of food-derived fatty acids, or their de novo biosynthesis by the nematode, whereas the biosynthesis of medium-chain <i>N</i>-acyl units depends on the peroxisomal β-oxidation cycle via the 3-ketoacyl-<i>S</i>-CoA thiolase <i>daf-22</i>. Glycosylation of these lipophilic <i>N</i>-acyl ethanolamines results in amphiphilic modular metabolites (approximately 100 identified compounds) that are released into the environment and exhibit potential signaling functions. Exclusively male-produced β-sophorosyl <i>N-</i>acyl-phosphoethanolamines like SNAP-13:1cyclo retain females of <i>Caenorhabditis wallacei</i> and <i>Caenorhabditis brenneri</i>, and its biosynthesis requires bacterial cyclo fatty acids 17:1cyclo and 19:1cyclo, thereby translating growth phase-dependent bacterial lipogeneses into a behavioral signal. Amphiphilic 2-(β-glucosyl)-glyceryl <i>N</i>-eicosapentaenoyl phosphoethanolamine (GGp-NAE-20:5), a dominating component of the <i>Caenorhabditis elegans</i> metabolome, represents a water-soluble derivative of <i>N</i>-eicosapentaenoyl ethanolamine (NAE 20:5), potentially enabling intra- and interspecies endocannabinoid signaling.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 4","pages":"602–619"},"PeriodicalIF":4.3,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsbiomedchemau.5c00012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144863071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-27DOI: 10.1021/acsbiomedchemau.5c00099
Annalisa Invernizzi, Francesco Nai, Rajiv Kumar Bedi, Pablo Andrés Vargas-Rosales, Yaozong Li, Elena Bochenkova, Marcin Herok, František Zálešák and Amedeo Caflisch*,
N6-Adenosine methylation is the most abundant modification of mRNA. The three members of the YTH domain family proteins (YTHDF1–3) recognize in the cytoplasm the m6A-RNA modification. We screened a library of about 500,000 fragments (i.e., molecules with 11–20 non-hydrogen atoms) by docking into YTHDF2, which resulted in the identification of six active compounds among 47 tested in vitro (hit rate of 13%). The acquisition of 28 analogues of the docking hits provided an additional set of 10 active compounds (IC50 < 100 μM). Protein crystallography-guided optimization of a ligand-efficient fragment by the synthesis of 32 derivatives culminated in a series of YTHDF2 ligands, which show low-micromolar affinity measured by a fluorescence polarization (FP) assay and a homogeneous time-resolved fluorescence-based (HTRF) assay. The series is characterized by very favorable ligand efficiency (of about 0.3–0.4 kcal/mol per non-hydrogen atom). Compound 23 binds to YTHDF2 according to the FP and HTRF assays with a Kd value of 1.3 μM and an IC50 value of 11 μM, respectively, and it is selective against all of the other YTH reader proteins. Several compounds of the series bind to the three YTHDF proteins with similar low-micromolar affinity, while they are less potent for YTHDC1 and YTHDC2. In contrast, compounds 17 and 30 bind also to YTHDC2, with Kd of 6.3 and 4.9 μM, respectively. We also disclose six crystal structures of YTHDF2 in the complex with the fragments identified by docking.
{"title":"Discovery of YTHDF2 Ligands by Fragment-Based Design","authors":"Annalisa Invernizzi, Francesco Nai, Rajiv Kumar Bedi, Pablo Andrés Vargas-Rosales, Yaozong Li, Elena Bochenkova, Marcin Herok, František Zálešák and Amedeo Caflisch*, ","doi":"10.1021/acsbiomedchemau.5c00099","DOIUrl":"https://doi.org/10.1021/acsbiomedchemau.5c00099","url":null,"abstract":"<p ><i>N</i><sup>6</sup>-Adenosine methylation is the most abundant modification of mRNA. The three members of the YTH domain family proteins (YTHDF1–3) recognize in the cytoplasm the m<sup>6</sup>A-RNA modification. We screened a library of about 500,000 fragments (i.e., molecules with 11–20 non-hydrogen atoms) by docking into YTHDF2, which resulted in the identification of six active compounds among 47 tested in vitro (hit rate of 13%). The acquisition of 28 analogues of the docking hits provided an additional set of 10 active compounds (IC<sub>50</sub> < 100 μM). Protein crystallography-guided optimization of a ligand-efficient fragment by the synthesis of 32 derivatives culminated in a series of YTHDF2 ligands, which show low-micromolar affinity measured by a fluorescence polarization (FP) assay and a homogeneous time-resolved fluorescence-based (HTRF) assay. The series is characterized by very favorable ligand efficiency (of about 0.3–0.4 kcal/mol per non-hydrogen atom). Compound <b>23</b> binds to YTHDF2 according to the FP and HTRF assays with a <i>K</i><sub>d</sub> value of 1.3 μM and an IC<sub>50</sub> value of 11 μM, respectively, and it is selective against all of the other YTH reader proteins. Several compounds of the series bind to the three YTHDF proteins with similar low-micromolar affinity, while they are less potent for YTHDC1 and YTHDC2. In contrast, compounds <b>17</b> and <b>30</b> bind also to YTHDC2, with <i>K</i><sub>d</sub> of 6.3 and 4.9 μM, respectively. We also disclose six crystal structures of YTHDF2 in the complex with the fragments identified by docking.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 4","pages":"753–765"},"PeriodicalIF":4.3,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/pdf/10.1021/acsbiomedchemau.5c00099","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144863065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}